Skip to main content
. 2019 Nov 14;10(11):867. doi: 10.1038/s41419-019-2098-8

Fig. 6. Proposed model of JQ1 and palbociclib activity in cisplatin-sensitive and resistant cell lines.

Fig. 6

a HNSCC cell at baseline. b HNSCC cell sensitive to cisplatin. c Cisplatin resistance confers palbociclib resistance. d JQ1 combined with palbociclib overcomes cisplatin resistance